Food drug lawyer and eight-year GPA head will remain an advisor to the group through the transition period. The $8M-revenue Generic Pharmaceutical Association announced the resignation of President and CEO Kathleen Jaeger, effective June 30. In a statement, GPA board chair Paul Bisaro announced Jaeger’s departure “with regret.” Jaeger “We are particularly grateful for her unprecedented success in broadening and strengthening our relationships with consumers, businesses, labor, state and federal agencies, pharmacy benefit managers and health plan purchasers,” said Bisaro. In addition to leading the group through a period of “tremendous growth” in revenue, Bisaro… Read More